Innovating Works

METAL ENGINEERING KNOWLEDGE-MECALBE

Activa
pBioStrat-for-PDA: Use of PAP as a biomarker and stratifier of pancreatic cancer to improve patient management INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un H2020: ERC-2017-PoC With an overall 3-year survival rate of only ~6% together with an increased incidence pancreatic ductal adenocarcinoma (PDA), which represen...
2018-05-28 - 2020-02-29 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.